{
  "variants": [
    {
      "variant_id": "R1441C",
      "gene": "LRRK2",
      "protein_change": "R1441C",
      "variant_string_id": "LRRK2 R1441C",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    {
      "variant_id": "R1441G",
      "gene": "LRRK2",
      "protein_change": "R1441G",
      "variant_string_id": "LRRK2 R1441G",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    {
      "variant_id": "R1441H",
      "gene": "LRRK2",
      "protein_change": "R1441H",
      "variant_string_id": "LRRK2 R1441H",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    {
      "variant_id": "Y1699C",
      "gene": "LRRK2",
      "protein_change": "Y1699C",
      "variant_string_id": "LRRK2 Y1699C",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    {
      "variant_id": "I1453M",
      "gene": "LRRK2",
      "protein_change": "I1453M",
      "variant_string_id": "LRRK2 I1453M",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    {
      "variant_id": "G2019S",
      "gene": "LRRK2",
      "protein_change": "G2019S",
      "variant_string_id": "LRRK2 G2019S",
      "steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism",
          "judgment": "Yes",
          "reason": "LRRK2 mutations are linked to Parkinson's disease. The study shows these variants disrupt phosphorylation of Ser 910/Ser 935, leading to disrupted 14-3-3 binding and inclusion bodies."
        },
        {
          "step": 2,
          "description": "Evaluate assay applicability",
          "judgment": "Yes",
          "reason": "Phosphorylation analysis and localization studies directly model the disease mechanism by showing how mutations affect protein function and localization."
        },
        {
          "step": 3,
          "description": "Basic controls and replicates",
          "judgment": "No",
          "reason": "The abstract does not explicitly mention replicates or control variants in the assays."
        },
        {
          "step": 3,
          "description": "Accepted assay",
          "judgment": "Yes",
          "reason": "Phosphorylation and localization assays are standard in the field and validated in prior studies."
        },
        {
          "step": 4,
          "description": "Statistical analyses",
          "judgment": "No",
          "reason": "The paper does not mention p-values, effect sizes, or OddsPath calculations."
        },
        {
          "step": 4,
          "description": "No OddsPath calculation",
          "judgment": "No",
          "reason": "The paper does not specify the number of control variants used in the study."
        },
        {
          "step": 4,
          "description": "Correlate OddsPath",
          "judgment": "N/A",
          "reason": "No OddsPath calculation or statistical analysis provided."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    }
  ]
}